A Clinician’s Perspective: Gene Therapy for X-Linked Myotubular Myopathy

Time: 8:45 am
day: Day One

Details:

  • -X-Linked Myotubular Myopathy (XLMTM): Burden of disease
  • Gene therapy and efficacy outcomes
  • Safety profile and liver toxicity

Speakers: